Literature DB >> 33234585

Feasibility of identifying and describing the burden of early-onset metabolic syndrome in primary care electronic medical record data: a cross-sectional analysis.

Jamie J Boisvenue1, Carlo U Oliva2, Donna P Manca2, Jeffrey A Johnson2, Roseanne O Yeung2.   

Abstract

BACKGROUND: The prevalence of metabolic syndrome is growing worldwide, yet remains underinvestigated in Canadian young adults. We sought to explore the use of a harmonized case definition specific to early-onset metabolic syndrome and determine its feasibility in assessing the prevalence of metabolic syndrome among electronic medical record (EMR) data of young adults in Northern Alberta.
METHODS: We conducted a cross-sectional study using a sample of EMR data from young adult patients aged 18-40 years and residing in Northern Alberta, who had an encounter with a participating primary care clinic between June 29, 2015, and June 29, 2018. Physical examination, laboratory investigation and disease diagnosis data were collected. A case definition and algorithm were developed to assess the feasibility of identifying metabolic syndrome, including measures for body mass index (BMI), blood pressure (BP), dysglycemia, hypertriglyceridemia, high-density lipoprotein cholesterol, diabetes and hypertension.
RESULTS: Among 15 766 young adults, the case definition suggested the prevalence of metabolic syndrome was 4.4%, 95% confidence interval (CI) 4.1%-4.7%. The most frequent 3-factor combination (41.6%, 95% CI 37.9%-45.3%) of metabolic syndrome criteria consisted of being overweight or obese, having elevated BP and hypertriglyceridemia. Half of metabolic syndrome cases (51.3%, 95% CI 47.6%-55.0%) were missing measures for fasting blood glucose, and one-fifth were missing a hemoglobin A1c (HbA1c) level. Notably, most young adults with a BMI of 25 or greater were missing HbA1c (68.7%, 95% CI 67.6%-69.8%), fasting blood glucose (84.0%, 95% CI 83.2%-84.8%) and triglyceride testing (79.0%, 95% CI 78.1%-79.9%).
INTERPRETATION: We have shown that our case definition is feasible in identifying early-onset metabolic syndrome using EMR data; however, the degree of missing data limits the feasibility in assessing prevalence. Further investigation is required to validate this case definition for metabolic syndrome in the EMR data, which may involve comparing this definition to other validated metabolic syndrome case definitions. Copyright 2020, Joule Inc. or its licensors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33234585      PMCID: PMC7721254          DOI: 10.9778/cmajo.20200007

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  32 in total

1.  Metabolic syndrome in a family practice population: prevalence and clinical characteristics.

Authors:  Caroline van den Hooven; Janneke Ploemacher; Marshall Godwin
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

2.  Anthropometric measurements as a potential non-invasive alternative for the diagnosis of metabolic syndrome in adolescents.

Authors:  Silmara Salete de Barros Silva Mastroeni; Marco Fabio Mastroeni; John Paul Ekwaru; Solmaz Setayeshgar; Paul J Veugelers; Muryel de Carvalho Gonçalves; Patrícia Helen de Carvalho Rondó
Journal:  Arch Endocrinol Metab       Date:  2019-02       Impact factor: 2.309

3.  Dyslipidemia.

Authors:  G B John Mancini; Robert A Hegele; Lawrence A Leiter
Journal:  Can J Diabetes       Date:  2018-04       Impact factor: 4.190

4.  Prevalence of metabolic syndrome in the Canadian adult population.

Authors:  Natalie D Riediger; Ian Clara
Journal:  CMAJ       Date:  2011-09-12       Impact factor: 8.262

5.  Metabolic syndrome and weight management programs in primary care: a comparison of three international healthcare systems.

Authors:  Elizabeth Sturgiss; Claire Deborah Madigan; Doug Klein; Nicholas Elmitt; Kirsty Douglas
Journal:  Aust J Prim Health       Date:  2018-11       Impact factor: 1.307

Review 6.  Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

7.  Increase of body mass index and waist circumference predicts development of metabolic syndrome criteria in apparently healthy individuals with 2 and 5 years follow-up.

Authors:  Eyal Fisher; Rafael Y Brzezinski; Michal Ehrenwald; Itzhak Shapira; David Zeltser; Shlomo Berliner; Yonit Marcus; Gabi Shefer; Naftali Stern; Ori Rogowski; Eran Halperin; Saharon Rosset; Shani Shenhar-Tsarfaty
Journal:  Int J Obes (Lond)       Date:  2019-01-15       Impact factor: 5.095

Review 8.  Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.

Authors:  Krithika Srikanthan; Andrew Feyh; Haresh Visweshwar; Joseph I Shapiro; Komal Sodhi
Journal:  Int J Med Sci       Date:  2016-01-01       Impact factor: 3.738

9.  Multi-cohort study identifies social determinants of systemic inflammation over the life course.

Authors:  Eloïse Berger; Raphaële Castagné; Marc Chadeau-Hyam; Murielle Bochud; Angelo d'Errico; Martina Gandini; Maryam Karimi; Mika Kivimäki; Vittorio Krogh; Michael Marmot; Salvatore Panico; Martin Preisig; Fulvio Ricceri; Carlotta Sacerdote; Andrew Steptoe; Silvia Stringhini; Rosario Tumino; Paolo Vineis; Cyrille Delpierre; Michelle Kelly-Irving
Journal:  Nat Commun       Date:  2019-02-15       Impact factor: 14.919

10.  Metabolic syndrome in canadian adults and adolescents: prevalence and associated dietary intake.

Authors:  Solmaz Setayeshgar; Susan J Whiting; Hassanali Vatanparast
Journal:  ISRN Obes       Date:  2012-11-20
View more
  2 in total

1.  Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults.

Authors:  Jeong-Ju Yoo; Eun Ju Cho; Goh Eun Chung; Young Chang; Yuri Cho; Sang-Hyun Park; Su-Min Jeong; Bo-Yeon Kim; Dong Wook Shin; Yun Joon Kim; Jung-Hwan Yoon; Kyungdo Han; Su Jong Yu
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

2.  Lower-Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia.

Authors:  Wael E Eid; Emma Hatfield Sapp; Elijah Flerlage; Joseph R Nolan
Journal:  J Am Heart Assoc       Date:  2021-09-01       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.